Low Expression of NQO1 Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Treated with TAC Regimen
Jiří Grim1, P. Jandík2, I. Slánská1, E. Doleželová-Brčáková3, L. Fuksa3, A. Ryška4, J. Knížek5, J. Petera1, S. Mičuda3, H. Hornychová4
1Department of Oncology and Radiotherapy, Charles University in Prague, Faculty of Medicine and University Teaching Hospital in Hradec Králové, Czech Republic 2Department of Surgery, Charles University in Prague, Faculty of Medicine and University Teaching Hospital in Hradec Králové, Czech Republic 3Department of Pharmacology, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic 4Department of Pathology, Charles University in Prague, Faculty of Medicine and University Teaching Hospital in Hradec Králové, Czech Republic 5Department of Medical Biophysics, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic
Received February 2012
Accepted May 2012
Crossref Cited-by Linking
Yang Dong, Chen Min-Bin, Wang Li-Qiang, Yang Lan, Liu Chao-Ying, Lu Pei-Hua: Bcl-2 expression predicts sensitivity to chemotherapy in breast cancer: a systematic review and meta-analysis. J Exp Clin Cancer Res2013, 32. <https://doi.org/10.1186/1756-9966-32-105>
